Managing Category A Waste in Healthcare: Key Preparedness Considerations

What is the Difference Between Category A Infectious Substances and Regulated Medical Waste

The definition of regulated medical waste (RMW) can vary at the federal, state, and local levels. In general, RMW refers to waste known or reasonably expected to contain a pathogen and generated through the diagnosis, treatment, or immunization of humans or animals, as well as through biomedical research and the production or testing of biological products. RMW may include items saturated with liquid or semi-liquid blood or other potentially infectious materials (OPIM), such as saturated disposable gowns, used gauze, and procedural drapes. Contaminated sharps—including used needles, scalpels, and in some cases syringes—may also qualify as RMW.

Category A infectious substances, by contrast, are subject to more stringent handling and packaging requirements because of the severity of the risk they present. Understanding that distinction is critical because classification drives handling, packaging, and transportation requirements. Category A infectious substances require specialized management and inactivation procedures designed to reduce the potential for life-threatening or fatal outcomes.

Strengthening Category A Waste Preparedness

Managing Category A infectious substances safely requires careful planning, particularly when facilities may be caring for patients with Ebola, Lassa Fever, or Marburg viruses that can generate substantial volumes of infectious waste. These scenarios can place immediate pressure on screening, isolation, storage, and transportation workflows. The latest Ebola outbreak in the Democratic Republic of the Congo and Uganda underscores the need for preparedness, including clear protocols for suspected cases, secure waste staging, and access to permitted transport. With the right management strategies in place, organizations are set up to respond safely and compliantly across the full lifecycle of infectious waste, from patients under investigation and initial waste generation through final treatment.

• Segregate Category A waste carefully: Effective management begins with on-site staff accurately identifying Category A waste keeping it separate from other solid and medical waste streams. If Category A waste is mixed with other waste, the entire contents should be managed as Category A. If hazardous waste is contaminated with Category A pathogens, management will need to be evaluated on a case-by-case basis. Because Category A waste demands dedicated storage areas, specific personal protective equipment (PPE), specialized packaging materials, and transportation processes that may require special permits, it is typically more resource-intensive and costly to manage. Careful consideration of what materials are brought into a patient’s room will help prevent unnecessary waste generation. Accurate classification is essential to avoid both under-management and unnecessary overclassification. Waste from patients under investigation or suspected cases should be labeled accordingly and stored separately from medical waste until diagnosis is confirmed.

• Follow strict packaging requirements: Disposal of Category A waste must comply with stringent Department of Transportation (DOT) packaging regulations. Given the hazards associated with Category A infectious substances, these wastes are subject to higher packaging standards than regulated medical waste to help prevent the spread of disease. Depending on the specific pathogen involved, additional requirements may apply under DOT special permits.

• Plan for compliant transportation: Once properly packaged, Category A waste must be transported in accordance with the Hazardous Materials Regulations (HMR) as explained in this overview, which may include a DOT special permit. Generally, DOT requires a confirmed Category A diagnosis before issuing a special permit for transport. Transportation planning should happen in advance, so organizations understand their waste hauler’s capability and interest in transporting Category A waste if permitted, before a case presents.

Navigating Category A Infectious Substances with a Reliable Partner

Category A waste readiness requires organizations to align internal policies with applicable regulations, operational realities, and vendor capabilities. An experienced waste management partner can help healthcare facilities navigate those complexities with greater confidence. WM has supported customers through major infectious disease events, including SARS in 2003, H1N1 in 2009, Ebola in 2014, and COVID-19 in 2020. Through collaboration with the Centers for Disease Control and Prevention and the U.S. Department of Transportation, WM has built deep expertise in compliant, safe handling and disposal of Category A waste. During the 2014 Ebola response, WM quickly mobilized and became the first company to receive party status on the DOT special permit to transport infectious substances generated during Ebola patient care.

WM continues to prepare for emerging public health threats while supporting healthcare organizations in managing complex waste streams safely, responsibly, and sustainably. With more than three decades of experience assisting hospitals and health systems during public health emergencies, including Ebola virus disease, the company is positioned to help customers strengthen their Category A waste preparedness and response capabilities.

This article is for general information purposes only and should not be construed as legal advice on any specific facts or circumstances.